1. |
Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health, 2004, 7(2): 204-215.
|
2. |
Willke RJ, Burke LB, Erickson P. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Control Clin Trials, 2004, 25(6): 535-552.
|
3. |
U. S. Food and Drug Administration (FDA). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. MD: U. S. FDA, 2009.
|
4. |
Lohr KN, Zebrack BJ. Using patient-reported outcomes in clinical practice: challenges and opportunities. Qual Life Res, 2009, 18(1): 99-107.
|
5. |
Greenhalgh J. The applications of PROs in clinical practice: what are they, do they work, and why. Qual Life Res, 2009, 18(1): 115-123.
|
6. |
Cella D, Hahn EA, Jensen SE, et al. Patient-reported outcomes in performance measurement. RTI Press, 2015.
|
7. |
Barbosa CD, Balp MM, Kulich K, et al. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence, 2012, 6: 39-48.
|
8. |
Mahmoudian A, Zamani A, Tavakoli N, et al. Medication adherence in patients with hypertension: does satisfaction with doctor-patient relationship work. J Res Med Sci, 2017, 22: 48.
|
9. |
Byun DW, Moon SH, Kim T, et al. Assessment of patient-reported outcomes (PROs): treatment satisfaction, medication adherence, and quality of life (QoL) and the associated factors in postmenopausal osteoporosis (PMO) patients in Korea. J Bone Miner Metab, 2019, 37(3): 563-572.
|
10. |
Prakash B. Patient satisfaction. J Cutan Aesthet Surg, 2010, 3(3): 151-155.
|
11. |
Guglieri M, Bushby K, McDermott MP, et al. Effect of different corticosteroid dosing regimens on clinical outcomes in boys with duchenne muscular dystrophy: a randomized clinical trial. JAMA, 2022, 327(15): 1456-1468.
|
12. |
Majewski S, Bhattacharya T, Asztalos M, et al. Sodium hypochlorite body wash in the management of Staphylococcus aureus-colonized moderate-to-severe atopic dermatitis in infants, children, and adolescents. Pediatr Dermatol, 2019, 36(4): 442-447.
|
13. |
von Mackensen S, Shah J, Seifert W, et al. Health-related quality of life in paediatric haemophilia B patients treated with rIX-FP. Haemophilia, 2019, 25(1): 45-53.
|
14. |
Bryant PA, Katz NT. Inpatient versus outpatient parenteral antibiotic therapy at home for acute infections in children: a systematic review. Lancet Infect Dis, 2018, 18(2): e45-e54.
|
15. |
Mueller-Godeffroy E, Vonthein R, Ludwig-Seibold C, et al. Psychosocial benefits of insulin pump therapy in children with diabetes type 1 and their families: the pumpkin multicenter randomized controlled trial. Pediatr Diabetes, 2018, 19(8): 1471-1480.
|
16. |
degl' Innocenti A, Hassing LB, Ingelgård A, et al. Measuring treatment satisfaction. A review of randomized controlled drug trials. Clin Res Regul Aff, 2004, 21(1): 39-47.
|
17. |
Johnston BC, Patrick DL, Devji T, et al. Cochrane handbook for systematic reviews of interventions version 6.2 (updated February 2021). Chapter 18: patient-reported outcomes. Cochrane, 2021.
|
18. |
郭秀花, 宁传华. 医学现场调查技术(案例版). 北京: 科学出版社, 2017.
|
19. |
Bassel M, Hanson KA. Measuring treatment satisfaction and preference in patients with asthma and COPD: results of a targeted literature review. Value Health, 2016, 19(7): A557-A558.
|
20. |
Prinsen CAC, Mokkink LB, Bouter LM, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res, 2018, 27(5): 1147-1157.
|
21. |
Mokkink LB, de Vet HCW, Prinsen CAC, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res, 2018, 27(5): 1171-1179.
|
22. |
Mokkink LB, Prinsen CA, Patrick DL, et al. COSMIN methodology for systematic reviews of patient-reported outcome measures (PROMs) - user manual version 1.0. 2018.
|
23. |
Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol, 2007, 60(1): 34-42.
|
24. |
Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol, 2011, 64(4): 383-394.
|
25. |
Clare B, Kate L, Alison W, et al. Development of the diabetes treatment satisfaction questionnaire (DTSQ) for teenagers and parents: the DTSQ-Teen and the DTSQ-Parent. Diabetologia, 2009, 52: S397.
|
26. |
Görtz-Dorten A, Breuer D, Hautmann C, et al. What contributes to patient and parent satisfaction with medication in the treatment of children with ADHD. A report on the development of a new rating scale. Eur Child Adolesc Psychiatry, 2011, 20(Suppl 2): S297-S307.
|
27. |
Sampson MJ, Singh H, Dhatariya KK, et al. Psychometric validation and use of a novel diabetes in-patient treatment satisfaction questionnaire. Diabet Med, 2009, 26(7): 729-735.
|
28. |
Rofail D, Gray R, Gournay K. The development and internal consistency of the satisfaction with Antipsychotic Medication Scale. Psychol Med, 2005, 35(7): 1063-1072.
|
29. |
Rofail D, Abetz L, Viala M, et al. Satisfaction and adherence in patients with iron overload receiving iron chelation therapy as assessed by a newly developed patient instrument. Value Health, 2009, 12(1): 109-117.
|
30. |
Elalfy MS, Massoud W, Elsherif NH, et al. A new tool for the assessment of satisfaction with iron chelation therapy (ICT-Sat) for patients with β-thalassemia major. Pediatr Blood Cancer, 2012, 58(6): 910-915.
|
31. |
Kempton C, Trask P, Parnes A, et al. Development and testing of the satisfaction questionnaire with intravenous or subcutaneous hemophilia injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVⅢ inhibitors. Haemophilia, 2021, 27(2): 221-228.
|
32. |
国家卫生健康委. 卫健委印发《国际疾病分类第十一次修订本(ICD-11)中文版》. 医学信息学杂志, 2019, 40(2): 95.
|
33. |
Churruca K, Pomare C, Ellis LA, et al. Patient-reported outcome measures (PROMs): a review of generic and condition-specific measures and a discussion of trends and issues. Health Expect, 2021, 24(4): 1015-1024.
|
34. |
Elalfy MS, Adly AM, Wali Y, et al. Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients. Eur J Haematol, 2015, 95(5): 411-420.
|
35. |
Scalone L, Mantovani LG, Krol M, et al. Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study. Curr Med Res Opin, 2008, 24(7): 1905-1917.
|
36. |
Porter J, Bowden DK, Economou M, et al. Health-related quality of life, treatment satisfaction, adherence and persistence in β-thalassemia and myelodysplastic syndrome patients with iron overload receiving deferasirox: results from the EPIC clinical trial. Anemia, 2012, 2012: 297641.
|
37. |
Bin-Abbas BS, Sakati NA, Al-Ashwal AA. Glycemic control and treatment satisfaction in Saudi diabetic children on insulin pump therapy. Ann Saudi Med, 2006, 26(3): 247-248.
|
38. |
Frielitz FS, Müller-Godeffroy E, Hübner J, et al. Monthly video-consultation for children with type 1 diabetes using a continuous glucose monitoring system: design of ViDiKi, a multimethod intervention study to evaluate the benefit of telemedicine. J Diabetes Sci Technol, 2020, 14(1): 105-111.
|
39. |
Troncone A, Chianese A, Cascella C, et al. Psychological outcomes in children and early adolescents with type 1 diabetes following pediatric diabetes summer camp: a 3-month follow-up study. Front Pediatr, 2021, 9: 650201.
|
40. |
von Sengbusch S, Schneidewind J, Bokelmann J, et al. Monthly video consultation for children and adolescents with type 1 diabetes mellitus during the COVID-19 pandemic. Diabetes Res Clin Pract, 2022, 193: 110135.
|
41. |
Rothenberger A, Becker A, Breuer D, et al. An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence. Eur Child Adolesc Psychiatry, 2011, 20(Suppl 2): S257-S265.
|
42. |
Haas J, Persson M, Brorsson AL, et al. Guided self-determination-young versus standard care in the treatment of young females with type 1 diabetes: study protocol for a multicentre randomized controlled trial. Trials, 2017, 18(1): 562.
|
43. |
Haas J, Persson M, Hagström Toft E, et al. Treatment satisfaction correlated with glycaemic control and burden of diabetes in Swedish adolescents with type 1 diabetes. Acta Paediatr, 2020, 109(3): 573-580.
|
44. |
Roh H, Kim B. A brief replication study comparing stimulants and non-stimulants for attention-deficit/hyperactivity disorder treatment with a focus on the compliance, efficacy, and satisfaction. Soa Chongsonyon Chongsin Uihak, 2021, 32(1): 10-16.
|
45. |
Malia L, Laurich VM, Sturm JJ. Adverse events and satisfaction with use of intranasal midazolam for emergency department procedures in children. Am J Emerg Med, 2019, 37(1): 85-88.
|
46. |
Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes, 2004, 2: 12.
|
47. |
Atkinson MJ, Kumar R, Cappelleri JC, et al. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health, 2005, 8(Suppl 1): S9-S24.
|
48. |
Bharmal M, Payne K, Atkinson MJ, et al. Validation of an abbreviated treatment satisfaction questionnaire for medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes, 2009, 7: 36.
|
49. |
Pouwer F, Snoek FJ, van der Ploeg HM, et al. A comparison of the standard and the computerized versions of the well-being questionnaire (WBQ) and the diabetes treatment satisfaction questionnaire (DTSQ). Qual Life Res, 1998, 7(1): 33-38.
|
50. |
Anderson RT, Skovlund SE, Marrero D, et al. Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther, 2004, 26(4): 565-578.
|
51. |
von Mackensen S, Gringeri A. Quality of life in hemophilia. Preedy VR, Watson RR, editors. Handbook of disease burdens and quality of life measures. New York: Springer, 2010: 1895-1920.
|
52. |
Ruiz MA, Pardo A, Rejas J, et al. Development and validation of the "Treatment Satisfaction with Medicines Questionnaire" (SATMED-Q). Value Health, 2008, 11(5): 913-926.
|
53. |
Luo X, Cappelleri JC. A practical guide on incorporating and evaluating patient-reported outcomes in clinical trials. Clin Res Regul Aff, 2008, 25(4): 197-211.
|
54. |
Pesudovs K, Burr JM, Harley C, et al. The development, assessment, and selection of questionnaires. Optom Vis Sci, 2007, 84(8): 663-674.
|
55. |
Matza LS, Swensen AR, Flood EM, et al. Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues. Value Health, 2004, 7(1): 79-92.
|
56. |
Eiser C, Varni JW. Health-related quality of life and symptom reporting: similarities and differences between children and their parents. Eur J Pediatr, 2013, 172(10): 1299-1304.
|
57. |
Upton P, Lawford J, Eiser C. Parent-child agreement across child health-related quality of life instruments: a review of the literature. Qual Life Res, 2008, 17(6): 895-913.
|
58. |
Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1-eliciting concepts for a new PRO instrument. Value Health, 2011, 14(8): 967-977.
|
59. |
Lasch KE, Marquis P, Vigneux M, et al. PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res, 2010, 19(8): 1087-1096.
|